Bristol Myers Squibb (BMY): Sotyktu: Miracle Pill for Autoimmune Dis...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	32
Posts	3289
Boards Moderated	0
Alias Born	08/31/2006

joe_techi

Re: None

Saturday, 09/10/2022 3:46:20 PM

Saturday, September 10, 2022 3:46:20 PM

Sotyktu: Miracle Pill for Autoimmune Diseases

"Given both deucravacitinib’s new mechanism of action and its very acceptable safety profile, it has the ability to make billions of dollars for Bristol-Myers Squibb. Well, it will give immeasurably suffering patients an extra chance for healing.

For U.S. patients, the price of Sotyktu is set at $6,146 (excluding discounts and rebates) for a one-month course of treatment. A year’s worth of therapy would cost $74,000. This is one-third more than the cost of treating psoriasis with Otezla (apremilast).

According to industry forecasts, deucravacitinib sales will reach $2.4 billion annually by 2026. Peak demand for deucravacitinib will easily reach $4 billion annually."

https://biopharma.media/deucravacitinib-miracle-drug-for-autoimmune-diseases-1094/